Clinical trial
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide…
NCT00037817 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00037817 |
|---|---|
| Title | Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies |
| Official title | Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Esophageal Cancers, Primary Small Cell Lung Cancers, Non-Small-Cell Lung Carcinoma, Pleural Mesotheliomas, Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura |
| Intervention type | Biological, Drug |
| Interventions | Decitabine, Depsipeptide, Celecoxib |
| Enrollment | 34 |
| Start date | May 17, 2002 |
| Primary completion | Oct 8, 2008 |
| Completion | Nov 9, 2009 |
| First posted | May 22, 2002 |
| Last update posted | Sep 30, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: